Doctor profile · Federal record

Dr. Rabia Parveez, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Fresno, CA

  • NPI 1922055680
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 44 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
7130 N Millbrook Ave
Fresno, CA 937203347
(559) 326-1222
fax (559) 326-1225
Additional location
1125 E Spruce Ave Ste 103
Fresno, CA 937203387
(559) 878-4510
fax (559) 878-4515
Mailing address
Po Box 25100
Fresno, CA 937295100

Credentials & registration

NPPES · NUCC
NPI registered
May 2006 — 20 yrs on file
Profile last updated
October 9, 2025
Year of graduation
1982 — 44 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
California #A70241

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1922055680. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
193,501
Distinct HCPCS
10
Medicare allowed
$1,302,942
HCPCS Description Services Patients Avg allowed
J1439 Injection, ferric carboxymaltose, 1 mg 58,500 59 $1
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 47,900 67 $3
Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram 36,180 12 $1
J0185 Injection, aprepitant, 1 mg 7,540 31 $2
J9263 Injection, oxaliplatin, 0.5 mg 6,800 17 $0
J9299 Injection, nivolumab, 1 mg 6,660 14 $30
J0897 Injection, denosumab, 1 mg 4,500 34 $23
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg 3,330 11 $45
J1627 Injection, granisetron, extended-release, 0.1 mg 3,300 23 $6
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 3,175 31 $0

In context: peer comparison

Among 8 peers in this city , average services per provider: 4,484. This provider delivers 43× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,916
Transactions
75
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals LP 11 $246.10
Celgene Corporation 19 $241.52
GlaxoSmithKline, LLC. 9 $201.93
Exelixis Inc. 5 $133.50
Daiichi Sankyo Inc. 5 $130.02
ABBVIE INC. 5 $123.65
Novartis Pharmaceuticals Corporation 5 $101.06
Lilly USA, LLC 2 $75.69
Takeda Pharmaceuticals U.S.A., Inc. 3 $67.04
Ipsen Biopharmaceuticals, Inc 2 $60.25
Merck Sharp & Dohme LLC 2 $59.05
PFIZER INC. 2 $57.05
Regeneron Healthcare Solutions, Inc. 2 $54.80
SOBI, INC 1 $46.33
E.R. Squibb & Sons, L.L.C. 2 $42.93

By nature of payment

Food and Beverage
$1,863
Education
$54

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
824
Patients
125
Total drug cost
$87,120
Drug Type Claims Patients Total cost
Anastrozole Generic 119 24 $2,482
Ondansetron Odt (Ondansetron) Brand 86 44 $1,422
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 74 18 $1,798
Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) Brand 64 11 $1,707
Eliquis (Apixaban) Brand 59 11 $39,315
Clinisol (Parenteral Amino Acid 15% No.5) Brand 52 0 $34,665
Prednisone Generic 52 17 $290
Warfarin Sodium Generic 51 0 $396
Alprazolam Generic 44 0 $324
Vancomycin Hcl Generic 43 0 $136

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Rabia Parveez's medical specialty?
Dr. Rabia Parveez practices Hematology & Oncology Physician in Fresno, CA.
Where does Dr. Rabia Parveez practice?
Dr. Rabia Parveez practices at 7130 N Millbrook Ave, Fresno, CA 937203347. Office phone: 5593261222.
What is Dr. Rabia Parveez's NPI?
Dr. Rabia Parveez's National Provider Identifier (NPI) is 1922055680, issued by NPPES.
Does Dr. Rabia Parveez accept Medicare assignment?
Yes. Dr. Rabia Parveez accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rabia Parveez commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram (HCPCS Q5125). Source: CMS Medicare Physician & Other Practitioners file.